GHGraeme Hoit

Graeme Hoit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Graeme Hoit has a total of 104 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel B. Whelan

    Department of Surgery, Division of Orthopaedic Surgery University of Toronto Toronto Ontario Canada

    9 shared publications
  • Amir Khoshbin

    Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada

    6 shared publications
  • Amit Atrey

    Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada

    5 shared publications
  • Jaskarndip Chahal

    Department of Surgery, Division of Orthopaedic Surgery, University of Toronto, Toronto, Ontario, Canada

    5 shared publications
  • Tim Dwyer

    Department of Surgery, Division of Orthopaedic Surgery, University of Toronto, Toronto, Ontario, Canada

    5 shared publications
  • Amir Khoshbin

    Division of Orthopaedics, University of Toronto, Toronto, ON, Canada

    4 shared publications

Latest Publications

  • Open Access

    The Tibial Sag Radiograph Is a Reliable Radiographic Technique to Quantify Posterior Cruciate Ligament Laxity

    by Geoffrey W. Schemitsch, Darius L. Lameire, Caroline Cristofaro, Graeme Hoit, Daniel B. Whelan

    Purpose: To evaluate the interobserver and intraobserver reliability associated with using tibial sag stress radiographs as a measure of posterior laxity in patients with posterior cruciate ligament injuries. Methods: All patients with posterior cruciate ligament injuries who underwent stress radiographic measurements using bilateral tibial sag stress radiographs and Telos stress radiographs between December 2018 and July 2024 were identified from an institutional database. All radiographs were measured by 3 independent blinded observers. The magnitude of posterior laxity was calculated by taking the side‐to‐side difference (SSD) in posterior tibial sag between the injured and uninjured limb. Clinical laxity of injured knees was assessed by a fellowship‐trained sports surgeon. Intraclass correlation coefficients (ICCs) were calculated to assess the interobserver and intraobserver reliability of each stress radiograph technique. Results: Among the 74 included knees, there were 26 (35.1%) grade I injuries, 39 (52.7%) grade II injuries, and 9 (12.2%) grade III injuries. The mean age of the cohort was 34.4 ± 12.1 years (range, 14‐67 years), and 54 (73%) were men. The tibial sag method showed good to excellent interobserver reliability (ICC 0.89, 95% confidence interval [95% CI] 0.84‐0.92) in measuring SSD. The Telos method showed moderate to good interobserver reliability (ICC 0.70, 95% CI 0.59‐0.78). The intraobserver reliability of measuring SSD using the tibial sag method was excellent for 2 reviewers (ICC 0.96, 95% CI 0.94‐0.97; ICC 0.95, 95% CI 0.92‐0.97) and good to excellent for 1 reviewer (ICC 0.91, 95% CI 0.86‐0.94). Conclusions: Tibial sag radiography is a reliable method that can be used to identify posterior displacement of the tibia relative to the femur as measured by SSD in patients with posterior cruciate ligament injuries. Level of Evidence: Level III, diagnostic retrospective comparative study.

  • Open Access

    The Incidence and Breadth of Postoperative Pudendal Nerve Palsy and Its Relationship to Table Traction During Hip Arthroscopy With a Perineal Post

    by Graeme Hoit, Tim Dwyer, Jaskarndip Chahal, Timothy A. Burkhart, Evan Curd, Shgufta Docter, Jordan Farag, John Theodoropoulos, Daniel B. Whelan

    Background: Pudendal nerve palsy (PNP) is a poorly characterized and underreported postoperative complication of hip arthroscopy (HA) with a perineal post. PNP may result in external genital numbness and sexual dysfunction in both men and women. Purpose: To describe the incidence, breadth, and duration of postoperative PNP symptoms and to evaluate the relationship between PNP and intraoperative limb traction. Study Design: Cohort study; Level of evidence, 3. Methods: All patients underwent primary unilateral HA in a supine position with a perineal post. Patients with preexisting PNP symptoms, including sexual dysfunction, were excluded. Intraoperative traction duration and force were recorded using a sensor applied to the perineal post. A PNP screening questionnaire and validated sexual function questionnaires were administered confidentially at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patient-reported hip outcomes (International Hip Outcome Tool–33 [iHOT-33]) were completed preoperatively and at 6 and 12 months. Results: A total of 93 patients were included (mean age, 36.4 years [SD, 9.2 years]; 55% male). The mean traction duration was 80 minutes (SD, 19 minutes). In the acute postoperative period, 77 (83%) patients experienced symptoms consistent with PNP. The most common symptoms were perineal numbness (75%), paresthesia (26%), and pain (18%). Urogenital or sexual dysfunction occurred in 39%, including erectile dysfunction in 22% of men and reduced sexual lubrication in 19% of women. At 3 months postoperatively, 26% of patients continued to have PNP symptoms, with 14% persisting to at least 6 months; all symptoms resolved by 12 months. Patients with PNP had greater traction force (MD, 18.1 kg; 95% CI, 0.3 to 37.1 kg) and longer traction time (MD, 15.4 minutes; 95% CI, 5.5 to 25.3 minutes). Longer traction duration was associated with increased odds of PNP (OR per additional 10 minutes, 1.59; 95% CI, 1.12 to 2.37). Persistence of symptoms beyond 6 weeks was associated with lower iHOT-33 scores at 6 months (MD, −14.4; 95% CI, −24.2 to −4.5). Conclusion: PNP symptoms were common after HA performed with perineal post traction, but most resolved within 6 months and all by 1 year. Increased traction duration and perineal pressure were significant predictors of symptom development, and persistent dysfunction correlated with lower hip-specific outcome scores.

  • PASS Thresholds and Denominators After Nonoperative Management of Femoroacetabular Impingement Syndrome: Response

    by Graeme Hoit, Daniel B. Whelan, Valerie Lemieux, Brent Bates, Tim Dwyer, John Theodoropoulos, Jaskarndip Chahal

  • Open Access

    Effect of a COntralateral corticoSTeroid Injection in total knee arthroplasty (COSTI) on postoperative patient reported outcomes: a randomised trial protocol

    by Bahar Entezari, Graeme Hoit, Cassandra Tardif-Theriault, Sarah Ward, Bheeshma Ravi, Seper Ekhtiari, Karim S Ladha, David Sussman, Amit Atrey, Amir Khoshbin

    Introduction: Knee osteoarthritis (OA) is a prevalent and debilitating condition, with nearly 50% of patients experiencing bilateral symptoms. Persistent contralateral knee pain after unilateral total knee arthroplasty (TKA) is a common contributor to suboptimal functional recovery and patient dissatisfaction. An intra-articular corticosteroid injection is a safe and widely used non-operative treatment for OA, but its perioperative utility in the contralateral (non-operative) knee to improve TKA recovery (operative side) remains underexplored. The CO ntralateral Cortico ST eroid I njection in Total Knee Arthroplasty (COSTI) trial is designed to investigate whether a single contralateral corticosteroid injection administered perioperatively improves patient-reported outcomes following unilateral TKA. Methods and analysis: The COSTI trial is a multi-centre, triple-blinded, randomised controlled superiority trial. An embedded pilot of 60 patients will first be used to assess the feasibility of the definitive trial. To preserve the integrity of the definitive trial, the pilot phase will focus on feasibility outcomes rather than treatment efficacy and no formal between-group analyses of clinical outcomes will be conducted prior to the progression decision. Treatment allocation will remain concealed from investigators and the study statistician throughout the pilot phase. The preliminary planned sample of the definitive trial will consist of 154 patients undergoing unilateral TKA for primary OA with symptomatic contralateral knee OA. Patients will be randomised 1:1 to receive either an ultrasound-guided contralateral intra-articular corticosteroid injection (80 mg methylprednisolone+0.5% bupivacaine/10 cc volume) or placebo (band-aid application) following the administration of spinal regional anaesthesia on the day of surgery. The primary outcome is change in Oxford Knee Score (OKS) from baseline to 4, 8 and 12 weeks and 1 year postoperatively. Secondary outcomes include contralateral knee pain (Visual Analogue Scale), EuroQol five-dimensional descriptive system, Timed Up and Go performance, range of motion, complications, readmissions and adverse events. The study is powered to detect a 5-point between-group difference in OKS with 90% power. Ethics and dissemination: This trial has received approval from the Unity Health Toronto Research Ethics Board (Protocol #24-158) and is registered at ClinicalTrials.gov ( NCT06809998 ). All participants will provide written informed consent. Findings will be disseminated through peer-reviewed publications and academic conferences, and pseudonymised data will be made available upon reasonable request. Trial registration number: NCT06809998 .

  • Open Access

    Treatment of Patients With Femoroacetabular Impingement Syndrome Using a Pelvic Tilt–Focused Exercise Program: A Prospective Cohort

    by Graeme Hoit, Daniel B. Whelan, Tim Dwyer, Sheilah Hogg-Johnson, Jaskarndip Chahal, Aileen M. Davis

    Background: The rates of hip arthroscopy are increasing worldwide for femoroacetabular impingement syndrome (FAIS). There is a lack of literature examining outcomes of modern nonoperative treatment of patients with FAIS. Purpose: To develop and assess the effectiveness of a pelvic tilt–focused exercise program for nonoperative management for patients with FAIS. Study Design: Cohort study; Level of evidence, 2. Methods: Eligible patients included those aged 16 to 55 years who met radiographic and clinical criteria for FAIS. Enrolled patients participated in a 10-minute standardized pelvic tilt–focused home exercise program (HipFit10) at least 4 times per week over 6 months. Self-reported adherence was tracked weekly. Patient-reported outcomes were collected at baseline and 3 and 6 months. The International Hip Outcome Tool–33 (iHOT-33) score was measured at baseline and 3 and 6 months, with the primary outcome being the iHOT-33 change score between baseline and 6 months. Secondary outcomes included the Hip Outcome Score–Activities of Daily Living (HOS-ADL), pain visual analog scale (pain VAS) score, crossover to surgical management, and complications. Results: A total of 214 patients were enrolled between August 2020 and October 2021. The mean age was 34.2 ± 10.2 years, and 121 (57%) patients were female. Within the study period, 19 of 214 (9%) patients dropped out or were lost to follow-up. By 6 months, 153 of 195 (78%) patients completed the intervention and elected to avoid surgery, and 42 of 195 (22%) patients signed up for or underwent surgery. The final iHOT-33 score was completed by 192 of 195 (98%) participants with mean improvement from baseline to 6 months of 11.7 (95% CI, 9.2 to 14.1; P < .001). By 6 months, 103 of 192 (54%) participants achieved the iHOT-33 minimal clinically important difference of 6.8. Significant improvements also were seen in the iHOT-33 score from baseline to 3 months (mean difference [MD], 7.6; 95% CI, 5.7 to 9.6) and from 3 months to 6 months (MD, 3.7; 95% CI, 1.8 to 5.6), as well as in the HOS-ADL (0-3 months: MD, 2.65; 95% CI, 0.8 to 4.4) and pain VAS score (0-3 months: MD, −7.7 [95% CI, −4.8 to −10.5]; 3-6 months: MD, −3.5 [95% CI, −0.6 to −6.3]). No adverse events were reported. Conclusion: In this study of patients with FAIS, pelvic tilt–focused physical therapy was utilized to improve patient function with 78% avoiding surgery. These results suggest the HipFit10 program is a safe and effective nonoperative option for patients with FAIS.

  • Open Access

    Oxidised zirconium heads show a lower linear wear rate than 28-mm metal heads against XLPE: a retrospective analysis

    by Amit Atrey, Zoe Thompson, Veronica Pentland, Richard McCalden, Kevin Gargan, Douglas Naudie, James P Waddell, Graeme Hoite, Amir Khoshbin

    Aims: The use of highly cross-linked polyethylene (XLPE) on the acetabulum has undoubtedly improved the wear rates and hence survivorship of total hip arthroplasty (THA). However, the importance of head tribology is not known. Oxidised zirconium (OxZr) was introduced to offer the lower wear rates of ceramic but the strength of metal. Whether OxZr heads have any purported benefits in terms of lowering wear is not known. This study therefore aims to compare wear rates of XLPE against metal and OxZr heads over a 10-year period. Methods: A previous study has suggested we need a minimum 95 cases to show a statistically significant difference. Thus, in this 10-year retrospective analysis we included 95 subjects with a primary THA with a 28-mm OxZr and 131 patients with a 28-mm cobalt-chrome (CoCr) head, both against XLPE liners. Linear and volumetric wear rate comparisons were performed using a validated 2-dimensional stereoisometric analysis by an independent centre. Results: There were no significant differences for any of the patient demographics between the 2 groups, with >60% women in both groups and normally distributed age. Cup inclination angle was also comparable between the 2 groups. While there was no difference in volumetric wear rates ( p = 0.7377), the annual linear wear rate for OxZr was 0.030 mm (95% CI, 0.024–0.036) compared with 0.046 mm (95% CI, 0.038–0.054) for CoCr, a statistically significant difference ( p = 0.0002) Conclusions: The widespread use of XLPE has revolutionised THA. This study is the first to show a statistically significantly lower wear rate with the use of OxZr. Whether this is enough to justify the cost differential and whether it translates to better implant survivorship is still to be determined. But if wear limiting wear rates is associated with decreasing revision rates, the use of ceramicised metal may be of clinical benefit.

  • Open Access

    The Patient Acceptable Symptom State for Commonly Used Patient-Reported Outcomes After Nonoperative Management of Hip Femoroacetabular Impingement Syndrome

    by Graeme Hoit, Daniel B. Whelan, Valerie Lemieux, Brent Bates, Tim Dwyer, John Theodoropoulos, Jaskarndip Chahal

    Background: Patient Acceptable Symptom State (PASS) values for commonly used patient-reported outcome measures are known for operatively treated patients with femoroacetabular impingement syndrome (FAIS) but have not been established for those undergoing nonoperative treatment. Purpose: First, to determine the PASS for International Hip Outcome Tool–33 (iHOT-33), Hip Outcome Score–Activities of Daily Living (HOS-ADL), and pain visual analog scale (VAS) in patients with FAIS treated nonoperatively; second, to assess the baseline factors that were associated with achieving PASS. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: Patients with FAIS who were treated nonoperatively with an expert-validated physical therapy protocol at 2 academic centers were prospectively enrolled. Patients completed the iHOT-33, HOS-ADL, and pain VAS at baseline and 6 months after beginning treatment. Receiver operating characteristic curve analyses were conducted to determine PASS cutoff points. Multivariable regression analyses were performed to determine the association of patient factors, radiographic markers, and disease severity on the likelihood of achieving PASS. Results: Of the 214 patients enrolled, 121 (57%) were female, and the mean age was 34 years. The median symptom duration before beginning the prescribed physical therapy regimen was 24 months. The mean (SD) iHOT-33 score was 42.9 (16.7) at baseline and 54.2 (22.0) at 6 months. The iHOT-33 score for PASS is 50 (specificity, 91%; sensitivity, 82%; area under the curve [AUC], 0.95). The mean (SD) HOS-ADL was 72.9 (16.0) at baseline and 77.1 (17.1) at 6 months. The HOS-ADL score for PASS is 66 (specificity, 81%; sensitivity, 86%; AUC, 0.90). The mean (SD) pain VAS score was 53.7 (23.1) at baseline and 41.9 (SD25.4) at 6 months. The pain VAS score for PASS is 36 (specificity, 67%; sensitivity, 85%; AUC, 0.87). Patient age was significantly predictive of achieving PASS for iHOT-33 (odds ratio, 1.04; 95% CI, 1.01-1.08). Patients with higher baseline iHOT-33 scores were more likely to achieve PASS for all patient-reported outcome measures ( P < .005). Otherwise, patient factors, radiographic markers, and symptom duration were not associated with achieving PASS. Conclusion: This study determined the PASS values for iHOT-33 (PASS = 50), HOS-ADL (PASS = 66), and pain VAS (PASS = 36) for patients with FAIS treated nonoperatively with an exercise-based, core-focused physical therapy program. These values can be utilized by clinicians in counseling individual patients to anticipated outcomes and by investigators for future nonoperative-focused outcomes research.


  • THE INCIDENCE AND BREADTH OF POSTOPERATIVE PUDENDAL NERVE PALSY AND ITS RELATIONSHIP TO TABLE TRACTION DURING HIP ARTHROSCOPY WITH A PERINEAL POST

    by G. Hoit, J. Chahal, T. Dwyer, T. Burkhart, S. Docter, J. Farag, D-B. Whelan

    Pudendal nerve palsy (PNP) is a poorly characterized but common postoperative complication of hip arthroscopy (HA) with a perineal post that can result in external genital numbness and sexual dysfunction in both men and women. Previous attempts to quantify the incidence of these symptoms have relied on patient-initiated reports, chart review, unvalidated questionnaires or have neglected the female experience all together – failures which likely underestimate the incidence of this complication. We aimed to describe the incidence of postoperative PNP, the breadth of symptoms patient experience and their duration, as well as establish the relationship between PNP and table traction. We utilized a multisurgeon prospective cohort of HA patients a single academic centre. All patients underwent primary unilateral hip arthroscopy, osteochondroplasty and labral repair in a supine position with a perineal post. Patients with pre-existing PNP symptoms, including sexual dysfunction, and those who were not sexually active were excluded. Intraoperative traction duration and force were recorded using a Tekscan sensor applied to the perineal post. A PNP screening questionnaire and standardized, validated sexual function questionnaires were administered confidentially to patients at 2-weeks, 6-weeks, 3-months and 6-months postoperatively. Patient reported hip function scores (iHOT-33) were completed preoperatively and at 6-months postoperatively. A total of 100 patients were enrolled. The mean age was 36.2+9.4 years, 56 patients (56%) were male. The mean traction duration was 80+19 minutes. In the acute postoperative period, 77 patients (77%) experienced symptoms consistent with PNP. The most common sensory symptom described was perineal numbness (n=77, 77%), followed by paresthesias (n=26, 26%). Seventeen men (17%) and thirteen women (13%) reported symptoms of sexual dysfunction postoperatively, in the form of erectile dysfunction (men) or reduced sexual lubrication/dyspareunia/anorgasmia (women). Of patients who experienced PNP symptoms (n=77), 21% had symptoms resolve by 6 weeks, 71% by 3 months, 90% by 6 months. Two male patients (3.6%) had persistent erectile dysfunction beyond 6 months postoperatively. Persistence of PNP symptoms beyond 6 weeks was associated with lower iHOT33 scores at 6 months (mean difference: 18.4 [95%CI: 6.5-30.4], p=0.003). Analysis of the calibrated sensor data to establish the relationship between traction force, pressure and duration with PNP is pending. In this preliminary analysis of a planned 100 patient cohort, patients experienced a high rate of PNP and sexual dysfunction symptoms following HA with perineal post, far higher than previous reports. The vast majority of symptoms resolved within the first 3-months post-operatively. Anticipated results from the sensor data within this ongoing study are likely to provide insight into the relationship between traction force and/or duration and PNP incidence. A post-less HA setup could be considered as an alternative given the described morbidity.

  • A New Angle on Outcomes: Introducing the Win Ratio to Orthopaedic Research

    by Sofia Bzovsky, Nathan N. O’hAra, Gerard P. Slobogean, Sheila Sprague, Daniel E. Axelrod, Graeme Hoit, Kiara Pannozzo, Rudolf W. Poolman


  • HIGH RATES OF PUDENDAL NERVE PALSY AND SEXUAL DYSFUNCTION FOLLOWING TABLE TRACTION DURING HIP ARTHROSCOPY WITH A PERINEAL POST: PRELIMINARY RESULTS OF A PROSPECTIVE COHORT

    by G. Hoit, J. Chahal, T. Dwyer, S. Docter, J. Farag, T. Burkhart, D.B. Whelan

    Pudendal nerve palsy (PNP) is a poorly characterized but common postoperative complication of hip arthroscopy (HA) with a perineal post that can result in external genital numbness and sexual dysfunction in both men and women. Previous attempts to quantify the incidence of these symptoms have relied on patient-initiated reports, chart review, unvalidated questionnaires or have neglected the female experience all together – failures which likely underestimate the incidence of this complication. We aimed to describe the incidence of postoperative PNP, the breadth of symptoms patient experience and their duration, as well as establish the relationship between PNP and table traction. We utilized a multisurgeon prospective cohort of HA patients a single academic centre. All patients underwent primary unilateral hip arthroscopy, osteochondroplasty and labral repair in a supine position with a perineal post. Patients with pre-existing PNP symptoms, including sexual dysfunction, and those who were not sexually active were excluded. Intraoperative traction duration and force were recorded using a Tekscan sensor applied to the perineal post. A PNP screening questionnaire and standardized, validated sexual function questionnaires were administered confidentially to patients at 2-weeks, 6-weeks, 3-months and 6-months postoperatively. Patient reported hip function scores (iHOT-33) were completed preoperatively and at 6-months postoperatively. The initial 83 cohort patients with 6-month follow-up were included in this preliminary analysis. Thirty-six patients (43%) were female with a mean age of 37+14 years and BMI of 24+3kg/m2. The mean traction duration was 81+19 minutes. Sixty-three patients experienced symptoms consistent with PNP in the acute postoperative period (75%). The most common sensory symptom described was perineal numbness (n=62, 75%), followed by paresthesia (n=22, 27%). Thirteen men (28%) and thirteen women (36%) reported symptoms of sexual dysfunction postoperatively, in the form of erectile dysfunction (men) or reduced sexual lubrication/dyspareunia/anorgasmia (women). Of patients who experienced PNP symptoms (n=63), 20% had symptoms resolve by 2 weeks, 60% by 6 weeks, 86% by 3 months, and 98% by 6 months postoperatively. The one patient whose symptoms persisted beyond 6 months reported persistent erectile dysfunction. Persistence of PNP symptoms beyond 6 weeks was associated with lower iHOT33 scores at 6 months (mean difference: 18.4 [95%CI: 6.5–30.4], p=0.003). Analysis of the calibrated sensor data to establish the relationship between traction force, pressure and duration with PNP is pending. In this preliminary analysis of a planned 100 patient cohort, patients experienced a high rate of PNP and sexual dysfunction symptoms following HA with perineal post, far higher than previous reports. The vast majority of symptoms resolved within the first 3-months post-operatively. Anticipated results from the sensor data within this ongoing study are likely to provide insight into the relationship between traction force and/or duration and PNP incidence. A post-less HA setup could be considered as an alternative given the described morbidity.